Tag: Mankind Pharma

Health

Mankind Pharma Bridges Digital Divide with ‘Digital Smart Class’ Initiative Across Rural India

Mar 29, 2024 by Praveen 0 Comments #Mankind Pharma, #Mankind Pharma Bridges, #Mumbai

Mumbai, 29th March, 2024: Mankind Pharma, one of India’s leading pharmaceutical companies, is making strides in enhancing the quality of education in remote areas through its ongoing ‘Digital Smart Class’ initiative. Under their CSR arm, this comprehensive program has established 220 smart classrooms equipped with cutting-edge technology across government schools in Uttar Pradesh, Uttarakhand, and Himachal Pradesh.

Mankind Pharma Bridges Digital Divide with 'Digital Smart Class' Initiative Across Rural India

The Digital Smart Class initiative is a strategic effort by Mankind Pharma to bridge the digital divide in education and provide underprivileged students with access to modern learning resources. The smart classrooms are equipped with integrated teaching devices, the Kyan system, which can convert any surface to an interactive board and multimedia playing surface, enabling a more engaging and immersive learning experience.

Mr. Sheetal Arora, CEO of Mankind Pharma, expressed his vision for the initiative, stating, “At Mankind Pharma, we are committed to contributing to the overall development of society. Education is a fundamental right, and we believe that every child, regardless of their geographical location, deserves access to quality education. The Digital Smart Class initiative is our endeavour to empower rural communities by providing them with the necessary tools and resources to thrive in the digital age.”

The initiative spans across 170 schools in 23 clusters, benefiting thousands of students in remote areas. Mankind Pharma has collaborated closely with local authorities and educational institutions to ensure the successful implementation and sustainability of the smart classrooms.

Key highlights of the Digital Smart Class initiative:

● Establishment of 220 smart classrooms across Uttar Pradesh, Uttarakhand, and Himachal Pradesh.

● Provision of integrated teaching devices and multimedia content for interactive learning.

● Comprehensive teacher training programs to ensure effective utilisation of the smart classroom technology.

● Three-year project management and maintenance support to ensure sustainability.

Mankind Pharma’s Digital Smart Class initiative aligns with the company’s commitment to corporate social responsibility and its vision of creating a positive impact on society. By leveraging technology and innovative educational resources, the company aims to empower rural communities and equip the younger generation with the skills and knowledge necessary to succeed in the digital era.

News

Social Beat Wins Digital D2C Mandate for Mankind Pharma

Dec 8, 2023 by Sujata Muguda 0 Comments #Mankind Pharma, #Mr Joy Chatterjee, #Social Beat, #Suneil Chawla

Leading digital marketing agency, Social Beat, has secured the D2C digital mandate for Mankind Pharma, one of India’s leading pharmaceutical companies after a multi-agency pitch. The partnership with Social Beat will mark a significant step forward in Mankind Pharma’s digital marketing efforts to strengthen its online presence and engage with a wider audience.

Mankind Pharma, known for its commitment to providing high-quality healthcare solutions, has chosen Social Beat as its digital partner to drive sales through the brand’s own website and drive growth in the digital space. With a diverse portfolio of pharmaceutical products, Mankind Pharma aims to connect with consumers across various demographics and geographies.

“We are delighted to be chosen as the digital marketing partner for Mankind Pharma,” said Suneil Chawla, Co-founder of Social Beat. “This collaboration presents a fantastic opportunity to leverage our expertise in digital marketing to help Mankind Pharma reach new heights in the online landscape. We look forward to crafting a highly impactful website and campaigns that resonate with Mankind Pharma’s objectives and growth.”

Social Beat, known for its data-driven approach and creative digital solutions, has a track record of delivering outstanding results for a wide range of clients across industries. The agency will be responsible for crafting and executing comprehensive digital marketing strategies for Mankind Pharma, encompassing various channels such as social media, search engine optimization (SEO), content marketing, and more.

Mr.Joy Chatterjee - Associate Vice President, Mankind

Speaking about the partnership, Mr Joy Chatterjee, AVP at Mankind Pharma, said, “In today’s digital age, it is imperative for us to have a strong online presence and engage effectively with our customers. Social Beat’s expertise in the digital marketing arena and their proven track record make them the ideal partner for our digital journey. We are excited about the opportunities this collaboration will bring and are confident that together, we will achieve great success.”

Social Beat’s experience in the pharmaceutical sector, coupled with its understanding of the Indian market, positions it well to assist Mankind Pharma in achieving its digital marketing objectives.

Health

Debunking the myths around Emergency Contraceptive Pills

Dec 27, 2021 by Gouri Achary 0 Comments #abortion, #Contraceptive Pills, #ECP, #Emergency Contraceptive Pills, #infertility, #Joy Chatterjee, #Mankind Pharma, #myths around Emergency Contraceptive Pills

By  – Joy Chatterjee, General Manager, Sales & Marketing, Mankind Pharma

Emergency Contraceptive Pills come to one’s rescue in effectively preventing unwanted pregnancy due to unprotected sex or cases when there is a contraceptive failure. It can be taken post-coitus to inhibit the process of fertilization. But according to WHO there is not much widespread use of ECP due to its lack of knowledge and where there is knowledge about ECP, people are not willing to use it because of the misconceptions looming around one’s fertility and safety.

Let’s debunk some of the common myths about Emergency Contraceptive Pills.

  • Myth – ECP cannot be purchased without Doctor’s Prescription     

Fact – Many are of the notion that buying ECP requires a valid prescription from a doctor. But on the contrary Emergency Contraceptive Pills can be easily bought over the counter from pharmacies, contraceptive clinics, hospitals, gynaecological and GP clinics without presenting any prescription or ID card.

  • Myth – Emergency Contraceptive Pills will not work after 24 hours

 Fact – As ECPs are also referred to as ‘morning-after pill,’ many believe that ECP should be taken the very next morning or in the worst case before the completion of 24 hours after having unprotected sex. Though it works best when taken at the earliest, it does not mean that it is a waste if taken post 24 hours. ECP’s work effectively for up to 3 days i.e. 72 hours after encountering unprotected sex and there are also some ECP’s that are valid for 5 days (120 hours) from the day of sex.

  • Myth – Taking pills more than once in a cycle can be dangerous and also lead to infertility

 Fact – Taking pills more than once in a cycle is not at all dangerous and is safe. Being exposed to high levels of hormones in Emergency Contraceptive Pills can disrupt the menstrual cycle, cause breast tenderness, stomach pain, nausea, vomiting, headache, tiredness but it will not lead to infertility or any serious health implications. But it must be noted that ECPs are not a regular form of contraception and other options must be considered if one is looking for prolonged contraception.   

  •  Myth – Emergency Contraceptive Pills are 100% effective

 Fact – One might think that taking ECP after coitus can successfully prevent pregnancy, but it is not always the case. There are various factors to be taken into account which ensure the effectiveness of the pills. The sooner the ECP is taken, the higher the chances of its 100% effectiveness. If taken in the later phase when ovulation has already taken place, then the functioning of ECP might be diluted. Also, if one is seeking other medication to cure illnesses like epilepsy, heartburn, etc. even then the benefits of ECP cannot be availed to the fullest.

  • Myth – ECP causes abortion

 Fact – ECP prevents pregnancy and does not end the pregnancy. It inhibits the fertilization of an egg either by stopping the release of the egg from the ovary or by preventing the implantation of the fertilized egg to the uterus. The pills work only when taken before pregnancy is established. If taken after the pregnancy, it does not have any effect on the existing pregnancy and does not harm the developing child.

 

 

Business

Gas-O-Fast strengthens its digital presence with a new campaign and messaging in the industry

Dec 16, 2021 by Gouri Achary 0 Comments #Ayurvedic antacid, #Gas-O-Fast, #Joy Chatterjee, #Mankind Pharma

Mankind Pharma’s ayurvedic antacid brand Gas-O-Fast sachets have rolled out a new campaign with content creators and food bloggers. Through this campaign, the brand tries to create awareness in the social media genre as maximum audiences rely on the content creators and bloggers.

Over the years, the brand has subsequently come up with campaigns that are more in a humorous zone. Similarly, Gas-O-Fast has executed an influencer activity engaging with comedy content creators with an aim to raise brand awareness in a fun and quirky way. The comedy content creators that are part of the campaign are Neel, Shirin Sewani, RJ Karishma, Indrani Biswas, Avnish.

Adding to this, the brand for the very first time has collaborated with Food bloggers as well. The influencer videos showcase how they end up eating a lot due to their professional choices and usually face acidity, gas and indigestion. Keeping this in mind the brand aims to drive relevance via contextual conversations and position them as the number one choice to enjoy food without any hesitation. To convey the messaging, the brand has collaborated with food bloggers such as Sarah Hussain, Nisha Rajput and Srishti & Vaibhav

The food bloggers have a following of mainly food lovers and enthusiasts, who love exploring various cuisines, and through this collaboration, the brand aims to raise awareness about Gas-O-Fast as the solution for all the over-eating and its benefits for food lovers. The overall campaign highlights and positions Gas-O-Fast sachets as a true companion for every celebration.

Talking about the new campaign, Joy Chatterjee, General Manager, Sales & Marketing of Mankind Pharma said, “We are focused towards building and establishing Gas-O-Fast sachets as the trusted ally for acidity, gas and Indigestion. We are aggressive towards building and strengthening our presence in the market. We have been coming up with interesting campaigns and collaborations to raise brand awareness and ensure optimum market share for our brand in the antacid industry. Gas-O-Fast sachets give quick relief from acidity, gas and indigestion. It is available with Jeera and Ajwain variants.

Gas-O-Fast is an Ayurvedic antacid brand from Mankind Pharma house, one of the leading pharmaceutical companies in India. Mankind Pharma and brands work towards the efforts of Make in India and Vocal for Local ideology. Gas-O-Fast has Ayurvedic antacid properties and its range of products are – Jeera, Ajwain, Guava and Lemon.

Business, News

Mankind Pharma celebrates the efforts of players who couldn’t win the medals but the hearts of all

Aug 12, 2021 by Rekha Nair 0 Comments #Managing Director and Vice Chairman of Mankind Pharma, #Mankind Pharma, #Mr. Rajeev Juneja

New Delhi: Mankind Pharma, the 4th largest pharmaceutical company in India has come forward to recognise the hard work and dedication of Indian athletes competing in the Tokyo Olympics. The brand will be rewarding players who represented India and garnered 4th position to salute them and encourage their determination and hard work.

Mankind Pharma will be facilitating the players with a token of appreciation and gratitude for their exceptional performance. It is not always about winning accolades and not all success is measured by bagging a trophy, the company believes that they may have lost out on a medal but they have won a billion hearts. Mankind understands the hardships faced by the athletes and has come forward to appreciate and acknowledge the spirit of the players. The pharma company has decided to give a total amount of 2.20 crore as a cumulative reward. Each player of the Women’s Hockey team, a total of 16 players, with 11 lakhs rupees and adding to that the Pharma company is rewarding Boxer Satish Kumar, Wrestler Deepak Punia, Shooter Saurabh Chaudhary and Golfer Aditi Ashok, who will be given a sum of INR 11 lakh each for their bravery and hard work.

Mankind Pharma believes that it’s not always about attaining that position on the podium, it’s the spirit with which all the players have performed and represented India.

Mankind Pharma has always supported the athlete community, and through such initiatives, it believes in justifying the true meaning of ‘Mankind’. The brand admires that sports should be promoted and appreciated in our country. As a company, Mankind Pharma always believes in supporting all those who bring fame for the nation and be a part of the growth and development of the nation.

Mr. Rajeev Juneja, Managing Director and Vice Chairman of Mankind Pharma, said, “We believe that in every sport it is not the win that counts, it’s the efforts that are counted and our players have put so much effort while representing our country. We have heard heart-warming stories of Olympic players who came from humble origins and have struggled to reach this stage. All such players have put in years of all hard work, many hail from small villages, live away with the family so their preparation doesn’t suffer. Despite all the problems, their courage and determination to represent the country at the biggest sporting event is exemplary. As a leader in the industry, we want to appreciate the hardships and sacrifices they have put in over the years. Such players inspire the whole country and motivate the younger generation to earn honours for the country.”

The Pharma company stand by these players who might have missed a medal, but they won everyone’s hearts. The staunchest of critics were made to sit up and applaud. These players have lost the medal but they have made sure to give a watershed moment for every Indian.

We are proud of all our players who put in so much of efforts. Jai Hind!

Business World

SafeKind toilet seat disinfectant spray launches first digital campaign on safe loo access to women

Jul 19, 2021 by Rekha Nair 0 Comments #General Manager- Sales and Marketing, #Mankind Pharma, #oy Chatterjee

New Delhi: SafeKind toilet seat disinfectant spray the personal hygiene brand from the house of Mankind Pharma has launched its first-ever digital campaign highlighting the importance of toilet seat sanitiser sprays while using the public toilet to prevent UTI.

The campaign features popular actor Delnaz Irani, and other women from different fields of life who share their personal experiences of using a public toilet. The video manifests that SafeKind toilet seat disinfectant spray will take care of women’s biggest worry by killing 99.9% of germs within a few seconds and protecting them from UTI (Urinary Tract Infection) while making sure consumer gets clean and fresh toilet every time. SakeKind toilet seat disinfectant spray gives a soothing fragrance and leaves a freshness after every spray.

With the campaign, SafeKind shares the message loud that there is no need to feel embarrassed, and girls can conquer the world like a pro with SafeKind Toilet Seat Disinfectant Spray.

The brand intends to educate people about the importance of sanitisation and prevent UTI which has become a major concern among women. The infection involves greater risk when one uses public washrooms that are often unclean and unhygienic. Apart from Toilet seats and toilet tops, it is important to spray the disinfectant on flush, faucets, doorknobs and other hard surfaces to avoid the chances of getting infected.

Commenting on the campaign, Joy Chatterjee, General Manager- Sales and Marketing, Mankind Pharma said, “With this campaign, we want the women to take charge of their well-being, and frequently start using SafeKind Toilet Seat Disinfectant Spray to stay safe from being infected. The COVID-19 infection has put a stressful need to maintain your personal hygiene consciousness, now more and more people are looking for such convenient products to remain free from any infection. But there is a greater need to aware people around adopting such products, our the objective is that women don’t have to deal with an ordeal experience when it comes to hygiene.”

Mankind Pharma, one of the leading pharmaceutical companies in India aspires to move towards a healthy nation.

Health

With Zinc, vitamin C and vitamin D, ‘Health OK’ improves body immunity

May 26, 2021 by Neel Achary 0 Comments #Mankind Pharma

Mankind Pharma, the 4th largest pharmaceutical company in India (As per IQVAI, TSA) expanded its OTC range of products last month. ‘Health OK’, a multivitamin and minerals tablet launched in 2013 as a part of the drug category, has now been incorporated in the OTC category as a food supplement. The company has a wide range of OTC products that are quite popular in the Indian market.

The decision has come at a time when the country is grappling with the second wave of the COVID-19 pandemic and there is an increased focus on preventive healthcare. Factors have increased the healthcare aspirations with busy schedules often leading to poor dietary choices that can cause health problems. In India, this has led to a high level of disease caused by nutrient deficiencies.

‘Health Ok’ multivitamin and minerals tablets contain Zinc, Vitamin D and Vitamin C which helps in building Immunity. ‘Health OK’ tablets with its unique formulations of Natural Ginseng and Taurine helps in maintaining energy and 20 multivitamin and minerals for improving overall health.

Today Vitamins, minerals and supplement category witnessing upward sales trend because of the wellness trend and increased awareness of VMS. VMS category is worth 5503 crores today, out of which multivitamins contribute 1211 crores and minerals contribute 2082 crores. Both categories continue to grow with a healthy trend. To be called as best multivitamins and tablets, one has to have the right ingredient with daily essential multivitamins and important minerals like Zinc.

In our daily routine, the food we eat plays a key role in maintaining the overall health and immunity of the body. But the prevailing conditions has urged all of us to focus on building our immunity stronger than ever. Health experts and Doctors have also underlined the importance of the intake of essential vitamins and minerals which are not commonly found in our diet and that must be taken in the form of supplements. Some of these include Zinc, Vitamin D and Vitamin C. All these elements prepare our body to fight the incoming infection.

Speaking on the initiative, Joy Chatterjee, General Manager- Sales and Marketing, Mankind Pharma said, “The Covid-19 pandemic has made us realise to focus on our overall health and immunity. If a person has weak Immunity he/she is more prone to get the infection. Hence, it is advised to take health supplements to build immunity which helps us fight against the infection. We are quite pleased with the fact that consumers are being aware of this, and have shown trust towards ‘Health OK tablets’, which builds immunity and overall health among people. The brand is fully committed to satisfy the aspiring needs and help consumers to get the best quality products.”

The brand last month roped in Anil Kapoor and Ranveer Singh as their brand ambassadors to promote and increase brand awareness of the product.

Business World, News

Grapes Digital bags the PR mandate for Mankind Pharma

May 21, 2021 by Rekha Nair 0 Comments #Founder and CEO, #General Manager, #Grapes Digital, #Himanshu Arya, #Joy Chatterjee, #Mankind Pharma, #Sales and Marketing

Mankind Pharma, the fourth largest pharmaceutical manufacturing company headquartered in India has appointed Grapes Digital to handle its PR mandate.

Grapes Digital’s Delhi office will be responsible for public relations strategy, planning and execution for Mankind Pharma and the seven brands under the corporate brand; Prega News, Manforce Condoms, Gas-O-Fast, Acnestar, Health OK, Safekind and Unwanted72. The agency will strengthen Mankind Pharma’s core brand value of being a trusted leader in the Pharmaceutical Industry, leveraging through an integrated communications approach combining strategic counselling and communication, media advocacy, crisis management and driving thought leadership in the pharma and healthcare space.

Commenting on the partnership, Joy Chatterjee, General Manager, Sales and Marketing, Mankind Pharma, said “We are extremely happy to associate with Grapes Digital as our communication partners. We believe that leveraging Grapes Digital’s expertise and long standing experience in the industry will enhance our brand visibility and connect with the target audience. We are confident this partnership will help us communicate our purpose as a brand and build the vision.”

Mr. Joy Chatterjee

Speaking on the win, Himanshu Arya, Founder and CEO, Grapes Digital said, “We are delighted that our deep and extensive understanding of corporate communications and a strong team have helped us win the mandate for Mankind Pharma, in their communication journey. We are keen on delivering result-oriented strategies and are delighted to leverage this association.”

Grapes Digital bags the PR mandate for Mankind Pharma

Grapes Digital is the fastest-growing digital-first marketing agency that is now aiming to grow in the PR industry as well and will be announcing the onboarding of more brands in the near future.

Business World

Mankind Pharma pays tribute to families of Frontline martyred warriors with Rs.100cr contribution during Covid

Apr 26, 2021 by Neel Achary 0 Comments #coronavirus pandemic, #healthcare and frontline workers, #Managing Director & Vice Chairman, #Mankind Pharma, #Mr. Rajeev Juneja

Hyderabad, 26th April 2021: As the country continues to grapple with the second wave of coronavirus pandemic, healthcare and frontline workers are racing against time to contain its spread. Many dedicated Heroes have lost their lives in the process. As a responsible organization, Mankind Pharma is standing alongside the families of these heroes and will donate Rs 100 crores to support them.

Mankind Pharma has been involved in the country’s fight against the pandemic since the beginning. In 2020 Mankind Pharma donated around INR 130 crore to the Prime Minister’s National Relief Fund, CM Care Fund, and to martyred healthcare workers and police personnel involved in fighting the pandemic. The company has donated ventilators, Personal Protective Equipment (PPE) and medicines to the nation. Being a leading pharma company, Mankind Pharma has always aspired to be recognized as a top brand both in revenue and serving mankind through its CSR activities.

Mr. Rajeev Juneja, Managing Director & Vice Chairman, Mankind Pharma, said, “Our fearless Heroes are doing their best to help people who are infected by Covid-19 or are suffering due to economic or social reasons brought about by the second wave of the pandemic. Being the first line of defense they are highly exposed to this deadly disease. Many have lost their lives fighting the pandemic and protecting us. Their invaluable service to the nation and humanity will not be forgotten. As a homage to them, we have pledged a fund of Rs 100 crore to support and care for the families of these lost warriors. This is not our duty, but a debt we owe them. Because they are truly our hope.”

Mr. Juneja added: “They have already fought many battles for us. It’s time, we fight for them. Let’s protect ourselves from the clutches of the coronavirus and, in turn, protect them.  Let us all promise to wear a mask whenever we step outside, maintain a distance of 6 feet at all times, and wash our hands regularly. Mankind Pharma will never forget the loss borne by the families of the deceased frontline warriors. The company knows we can never do enough to replace their void but we can at least try to help them ride through these trying times.”

Mankind Pharma pledge to donate a sum to Rs 100 cr for the families of deceased doctors, police officers, pharmacists, and other healthcare workers.

Business World

Mankind Pharma seeks CDSCO’s nod to conduct Phase 1 Clinical Trials of patented first in class Novel Anti-Diabetic Molecule

Apr 14, 2021 by Neel Achary 0 Comments #Mankind Pharma

Mankind Pharma, the 4th largest pharmaceutical company in India (As per IQVIA) today submitted its first Investigational New Drug (IND) application for approval to the Indian Drug Regulatory Authority, Central Drugs Standard Control Organisation(CDSCO) for MKP10241, a patented first in Class Novel Anti Diabetic Molecule.

The company has worked relentlessly in developing this new class of anti-diabetic molecules- designed and developed at the Mankind Research Centre. MKP10241 is a potent and orally administered small molecule, GPR119 agonist. GPR 119 is highly expressed in pancreatic beta cells and intestinal enteroendocrine cells.

With subsequent approval by CDSCO and launch of this first in class drug, the company strongly anticipates that it will be of immense benefit to the diabetic patients, and will prove to be extremely effective in lowering blood sugar levels.

mankind

What makes MKP10241 unique is its mechanism of action. GPR119 elevates intracellular secondary messengers such as cAMP inside the cells and promotes postprandial insulin and incretin secretion (GLP-1) in a glucose-dependent manner. This dual mechanism by GPR119 in mediating glucose-dependent insulin secretion is distinct from the currently available therapeutic options for Type 2 diabetes and thus becomes a promising new approach for the treatment of type 2 diabetes and related metabolic disorders.

The small molecules with GPR119 agonist property would help the Indian pharma industry to provide a new therapeutic option in the antidiabetic armamentarium for the cliniciansin the management of type 2 diabetes.

The new drug was tested in multiple preclinical models of Type 2 diabetes to understand the mechanism of action and efficacy, and has shown effective results in reducing blood sugar levels and glycated hemoglobin. MKP10241 elevates plasma insulin as well as plasma GLP-1 levels ultimately leading to reduced plasma glucose in preclinical models validating the dual mechanism of action associated with GPR119.

MKP10241 has already been granted patents worldwide till 2037.

Speaking on this historicoccasion, Shri RC Juneja, Executive Chairman, Mankind Pharma said, “Our team of scientists have worked tirelessly& with immense passionto develop this novel drug to benefit the people, and it will be affordable for patients. Mankind Pharma is committed to expanding its portfolio of products in the Indian market in all major therapeutic areas for the benefit of patients, prescribers and the healthcare system.”

The company believes if we can provide the right drug in right doses to the right patient by the right route at the right time; it will eventually strengthen &improve the health care system effectively. The company has a strong presence in pharmaceutical, veterinary, OTC & FMCG segments.